1
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S. P., Zijlstra, Josee M., Chamuleau, Martine, Kersten, Marie José, Durmaz, Mujde, Plattel, Wouter J., Lugtenburg, Pieternella J., Stevens, Wendy, Mous, Rogier, de Vries, Elisabeth G. E., van der Poel, Marjolein W. M., Panday, Prashant V. Nannan, Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: A Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/BLOODADVANCES.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: A Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/BLOODADVANCES.2021004295;
2021
2
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S. P., Zijlstra, Josee M., Chamuleau, Martine, Kersten, Marie Jose, Durmaz, Mujde, Plattel, Wouter J., Lugtenburg, Pieternella J., Stevens, Wendy, Mous, Rogier, de Vries, Elisabeth G. E., van der Poel, Marjolein W. M., Panday, Prashant V. Nannan, Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
3
Pennings, Elise R.A., Durmaz, Müjde, Visser, Otto, Posthuma, Eduardus F.M., Issa, Djamila E., Chamuleau, Martine E.D., Spanjaart, Anne M., van Meerten, Tom, Mutsaers, Pim G.N.J., Jak, Margot, van Dorp, Suzanne, Vermaat, Joost S.P., van der Poel, Marjolein W.M., Kuipers, Maria T., Thielen, Frederick W., Uyl-de Groot, Carin A., Lugtenburg, Pieternella J., José Kersten, Marie, Dinmohamed, Avinash G.
Veröffentlicht in: HemaSphere ; volume 7, issue S3, page e992046d ; ISSN 2572-9241;
2023
Veröffentlicht in: HemaSphere ; volume 7, issue S3, page e992046d ; ISSN 2572-9241;
2023
4
Spanjaart, Anne M., Pennings, Elise R.A., Mutsaers, Pim G.N.J., van Dorp, Suzanne, Jak, Margot, van Doesum, Jaap A., de Boer, Janneke W., Niezink, Anne G.H., Kos, Milan, Vermaat, Joost S.P., Sijs-Szabo, Aniko, van der Poel, Marjolein W.M., Nijhof, Inger S., Kuipers, Maria T., Chamuleau, Martine E.D., Lugtenburg, Pieternella J., Doorduijn, Jeanette K., Serroukh, Yasmina I.M., Minnema, Monique C., van Meerten, Tom, Kersten, Marie José
Veröffentlicht in: Spanjaart , A M , on behalf of the Dutch CAR-T Tumorboard Consortium , Pennings , E R A , Mutsaers , P G N J , van Dorp , S , Jak , M , van Doesum , J A , de Boer , J W , Niezink , A G H , Kos , M , Vermaat , J S P , Sijs-Szabo , A , van der Poel , M W M , Nijhof , I S , Kuipers , M T , Chamuleau , M E D , Lugtenburg , P J , Doorduijn , J K , Serroukh , Y I M , Minnema , M C , van Meerten , T & Kersten , M J 2023 , ' The Dutch CAR-T Tumorboard Experience : Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands ' , Cancers , vol. 15 , no. 17 , 4334 . https://doi.org/10.3390/cancers15174334;
2023
Veröffentlicht in: Spanjaart , A M , on behalf of the Dutch CAR-T Tumorboard Consortium , Pennings , E R A , Mutsaers , P G N J , van Dorp , S , Jak , M , van Doesum , J A , de Boer , J W , Niezink , A G H , Kos , M , Vermaat , J S P , Sijs-Szabo , A , van der Poel , M W M , Nijhof , I S , Kuipers , M T , Chamuleau , M E D , Lugtenburg , P J , Doorduijn , J K , Serroukh , Y I M , Minnema , M C , van Meerten , T & Kersten , M J 2023 , ' The Dutch CAR-T Tumorboard Experience : Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands ' , Cancers , vol. 15 , no. 17 , 4334 . https://doi.org/10.3390/cancers15174334;
2023